Table 1 Baseline characteristics of patients
PlaceboStrontium ranelatep Value*
N  =  185N  =  168
Age, years60 (3.4)60 (3.6)NS
Years since menopause13.4 (6.1)13.5 (6.0)NS
BMI (kg/m2)26.126.7NS
⩾1 Prevalent vertebral fracture (%)153 (82.7)131 (78.0)NS
Previous non-vertebral fracture (%)50 (27.0)31 (18.5)NS
Bone mineral density
    Lumbar spine T score−3.7 (1.0)−3.5 (1.2)NS
    Femoral neck T score−2.5 (0.8)−2.5 (0.8)
    Femoral neck T score (NHANES III reference)−1.92−1.92
  • Data are presented as mean values (SD).

  • *Wilcoxon test between the two groups of treatment.

  • BMI, body mass index; NHANES, National Health and Nutrition Examination Survey III.